Ivo Demel
5PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 14, 2025
Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment.Anjana Anilkumar Sithara, Veronika Kapustova, David Zihala
|Dec 23, 2024
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID-19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř
|Dec 13, 2023
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.Ivo Demel, David Skopal, Eliška Šafránková
|Mar 14, 2022
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies.Ivo Demel, Zdenek Koristek, Benjamin Motais
|Nov 20, 2020
Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021.Ivo Demel, Julio Rodriguez Bago, Roman Hajek
Pageof 1
Frequent Collaborators
2 joint publications
Roman Hajek
2 joint publications
Tomas Jelinek
2 joint publications
Tereza Popková
2 joint publications
Ludmila Muroňová
1 joint publications
Ondrej Šušol
1 joint publications
Anjana Anilkumar Sithara
1 joint publications
Veronika Kapustova
1 joint publications
David Zihala
1 joint publications
Ondrej Venglar
1 joint publications
Daniel Bilek
